WHO ICTRP trial
A mulit-center, randomized, double-blind, placebo-controlled, four-arm parallel…
EUCTR2005-000428-18-AT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-000428-18-AT |
|---|---|
| Public title | A mulit-center, randomized, double-blind, placebo-controlled, four-arm parallel group trial to investigate the efficacy and safety of three different transdermal doses of rotigotine in subjects with idiopathic restless legs syndrome |
| Scientific title | A mulit-center, randomized, double-blind, placebo-controlled, four-arm parallel group trial to investigate the efficacy and safety of three different transdermal doses of rotigotine in subjects with idiopathic restless legs syndrome |
| Primary sponsor | Schwarz Biosciences GmbH |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland;Spain;Austria;Germany;Italy;United Kingdom;Sweden |
| Conditions | Restless Leg's Syndrome MedDRA version: 7.0 Level: LLT Classification code 10058920 |
| Interventions | Product Name: Rotigotine Product Code: SPM 936 Pharmaceutical Form: Transdermal patch INN or Proposed INN: Rotigotine CAS Number: [99755-59-6] Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 2.25… |
| Registration date | May 4, 2005 |
| Target size | 450 |
| Secondary IDs | SP790 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: